Patents by Inventor Nathan Wegmann

Nathan Wegmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • System and methods for analyzing blood glucose data and quantifying the success or failure of insulin therapy
    Patent number: 10102344
    Abstract: A system and technique are enclosed for determining the effectiveness of a blood glucose therapy treatment. Examples of this technique include analyzing sufficiency of blood glucose data collected from a patient with a computing device, analyzing hypoglycemic risk based on the blood glucose data with the computing device, analyzing glycemic control for the blood glucose data with the computing device, analyzing glycemic variability of the blood glucose data with the computing device, and outputting results from said analyzing the sufficiency, said analyzing the hypoglycemic risk, said analyzing the glycemic control, and said analyzing the glycemic variability with the computing device.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: October 16, 2018
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Christen A Rees, Robin Wagner, Nathan Wegmann
  • System and Methods for Analyzing Blood Glucose Data and Quantifying the Success or Failure of Insulin Therapy
    Publication number: 20140278124
    Abstract: A system and technique are enclosed for determining the effectiveness of a blood glucose therapy treatment. Examples of this technique include analyzing sufficiency of blood glucose data collected from a patient with a computing device, analyzing hypoglycemic risk based on the blood glucose data with the computing device, analyzing glycemic control for the blood glucose data with the computing device, analyzing glycemic variability of the blood glucose data with the computing device, and outputting results from said analyzing the sufficiency, said analyzing the hypoglycemic risk, said analyzing the glycemic control, and said analyzing the glycemic variability with the computing device.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 18, 2014
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Christen A Rees, Robin Wagner, Nathan Wegmann